Perceptions on Management of Atopic Dermatitis in Children Under 2 Years by Community Pediatricians: A Focus Group Study.

Autor: Hamideh N; NYU Langone Grossman School of Medicine, New York, NY, USA., Venkatesh P; University of Texas Southwestern Medical Center, Dallas, TX, USA., Zhao S; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Ariza AJ; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Bolanos L; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Necheles J; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA., Fishbein AB; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Jazyk: angličtina
Zdroj: Clinical pediatrics [Clin Pediatr (Phila)] 2023 Oct; Vol. 62 (10), pp. 1176-1185. Date of Electronic Publication: 2023 Feb 16.
DOI: 10.1177/00099228231154132
Abstrakt: Atopic dermatitis (AD) is a common skin condition and is undertreated in children under 2 years, whom there are no specific guidelines for. We sought to understand barriers to AD treatment and primary care pediatricians' (PCPs) suggested solutions. We conducted semi-structured focus groups (n = 5) with PCPs (n = 17) on how the undertreatment of AD can be addressed. Data were analyzed using an inductive qualitative approach. Participants noted that the perceived undertreatment of AD in children under 2 years could be explained by topical corticosteroid (TCS) use hesitancy, lack of caregiver adherence to PCP recommendations, and under-documentation of AD in the electronic medical record (EMR). Proposed suggestions for improving AD management included caregiver and PCP education on TCS safety; stepwise management guidelines for this age group; and EMR aids to help document and manage AD. Research is warranted to create and disseminate clinician-friendly AD management guidelines for this age group.
Databáze: MEDLINE